Forbes June 5, 2023
Robert Hart

Topline

Neuralink, Elon Musk’s brain implant company, has won approval from the Food and Drug Administration to start testing its device in humans, one of a growing cadre of neurotech pioneers with goals of merging humans with machines to treat a range of medical conditions such as paralysis, blindness and depression—and enhance existing abilities like memory or allow us to interact with computers by thought alone.

Key Facts

News Peg

In late May, Neuralink announced it had secured FDA approval to launch its first “in-human clinical study.” The decision “represents an important first step that will one day allow our technology to help many people,” the firm said, adding that it was the result of “incredible work” by the Neuralink...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Provider, Technology
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.
AI degrades our work, nurses say
What If Generative AI Turned To Be A Flop In Healthcare?

Share This Article